SBC
SBC Medical Group Holdings Inc$5.32 +0.04 (+0.76%)
Oct 26 4:00 PM ET · prev $5.28
Market cap
$585.2M
Small cap
Consensus
Buy
86% Buy or better · 7 analysts
Median target
$8.50
+60% · range $7.00–11.00
Next earnings
Nov 13
in 18 days · EPS est. $0.12
1 year
+43.4%
from $3.71 · Oct 27
30 days
+5.8%
from $5.03
52-week range
$2.87–5.69
−7% from high · low May 18
Avg volume 20D
185.1K
shares / day
Short interest
813.9K
≈0.8% of shares · +13.4%
Days to cover
3.4
at average volume
Insider net
-$20.2M
0 buyers · 1 seller · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
SecBot read BEARISH 1 report · latest
Balance 1 bearish · 0 bullish oldest → newest, height = score
Avg score ·High conf. 1/1 ·Next Earnings date, Nov 13, 2026
Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
No data for this timeframe.
- S Mar 6 1 insider sell $9.4M at $2.12
- S Apr 21 to Apr 28 2 days of insider sells: $10.8M by 1 insider, avg $3.02
- R Jul 14 SBC Medical Group Holdings disclosed it is non-compliant with Nasdaq…
- X Jul 15 Short interest jumps 66.6% to 914.8K
Signal stack
Where each data set points today.
- InsidersBEARISH
1 insider sold $20.2M.
- InstitutionsBULLISH
Q2 2026: 23 added (0 new), 1 trimmed or exited.
- AnalystsBULLISH
6 of 7 rate it Buy or better. Every target is above the price.
- EstimatesFALLING
Current-quarter EPS estimate $0.120 → $0.117 over 90 days. 2 up, 2 down in 30 days.
- Short sellersSTEADY
Short interest +13.4% to 813.9K shares. 3.4 days to cover, ≈0.8% of shares.
- TrendUPTREND
12% above its 50-day average. New closing high $5.69 on Oct 22.
- SocialQUIET
Crowd 50° (neutral) this week from 5 mentions: 0 bullish, 0 bearish. No setup call. Excludes 1 subscriber-only day.
Who's buying
13F· Q2 20260
new positions
0
exits
| Fund | Move | Value |
|---|---|---|
| BlackRock, Inc. | DOUBLED | $2.8M |
| GEODE CAPITAL MANAGEMENT, LLC | ADD | $1.3M |
| NORTHERN TRUST CORP | ADD | $404.1K |
| VANGUARD PORTFOLIO MANAGEMENT LLC | DOUBLED | $395.1K |
| STATE STREET CORP | ADD | $151.7K |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | DOUBLED | $144.3K |
| Mariner, LLC | ADD | $103.9K |
| Bank of New York Mellon Corp | DOUBLED | $83.1K |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
7 analysts 86% rate it Buy or better
12-month targets · 4 analysts
$5.32 $7.00 $8.50 $11.00
Price is below the lowest target. Median implies +60%.Targets as of Oct 26, 2026.
Recent actions
| Date | Firm | Rating |
|---|---|---|
| Aug 13, 2026 | BTIG REITERATE | Buy |
Insider ledger
Form 4$0
bought · 0 insiders
$20.2M
sold · 1 insider
| Date | Insider | Type | Value |
|---|---|---|---|
| Apr 28, 2026 | Aikawa Yoshiyuki Chairman and CEO | SELL | $1.4M |
| Apr 21, 2026 | Aikawa Yoshiyuki Chairman and CEO | SELL | $9.4M |
| Mar 6, 2026 | Aikawa Yoshiyuki Chairman and CEO | OTHER | 44,229 sh |
| Mar 6, 2026 | Aikawa Yoshiyuki Chairman and CEO | OTHER | 44,229 sh |
| Mar 6, 2026 | Aikawa Yoshiyuki Chairman and CEO | SELL | $9.4M |
Earnings setup
EstimatesNov 13
reports in 18 days
$0.12
EPS estimate, this quarter
−2%
estimate change, 90 days
2↑ 2↓
revisions, 30 days
Current-quarter EPS estimate
$0.12090d
$0.12060d
$0.11730d
$0.1177d
$0.117Now
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | $0.12 | $0.10–$0.13 | +0.0% | $48.9M |
| Next Q | $0.12 | $0.10–$0.13 | +0.0% | $49.8M |
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Reddit mentions per day, 14 days
Crowd this week 50° Neutral 0 bullish · 0 bearish
Mentions, 7 days 5 2 in posts · 3 in comments
Recent posts
Buying Meta at Dirt Cheap Prices
1 upvotes · 0 comments
Buying Meta at Dirt Cheap Prices
0 upvotes · 40 comments
Tesla / Space X time to buy or to hold?
1 upvotes · 15 comments
Palantir at ~$500B: can someone show me where my valuation math is wrong?
1 upvotes · 6 comments
Free Cash Flow: NVIDIA vs reddit
1 upvotes · 0 comments
Recent comments
Fresh comment, for subscribers
People like you are not build for buying individual stocks. Because if you built a diversified portfolio of 8 or so names in differnet sectors with reasonable valuations and most importantly THEY ARE PROFITABLE. You would perhaps be down around like a little more than the sp500 but not that much. That is because the weighted BETA is not much more than the SP500.
You bought shit companies that are highly speculative, high beta, enourmous SBC and shareholder dilution. No buyback support. and so
Great catch! my math wasn’t mathing. Updated the post. Certainly FCF isn’t the best metric that’s for sure. You could probably back out growth capex from FCF and adjust from there (with SBC), but EV/OCF was mainly used as a reliable indicator of valuation that you could compare across two time periods.
I agree with the distinction between Meta being a great business and being priced like it was in 2022. Those are very different propositions..One numerical correction, though: buying at $155 in 2022 and reaching roughly $649 today would produce about a 319% price return, but the annualized return over approximately four years is closer to 43%, not 72%. Still exceptional, just a different CAGR.I also think your SBC adjustment is important, particularly with Meta reporting about $7.3B in quarterly
Short side
FINRA· Sep 30, 2026813,900
shares short
+13.4%
vs prior settlement
3.4
days to cover
≈0.8%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 25, 2026 Other
Jul 14, 2026 SEC SBC Medical to Participate in Several Upcoming Investor Conferences in October 2026
SBC Medical announces its participation in 3 upcoming investor conferences in Oct 2026, featuring pr
SBC Medical Group Holdings disclosed it is non-compliant with Nasdaq's independent director and audit committee…
8-K — Impact 6/10
Jun 30, 2026 Inst.
BlackRock, Inc. — DOUBLED
924,002 shares ($2.8M)
Jun 30, 2026 Inst.
May 22, 2026 Press GEODE CAPITAL MANAGEMENT, LLC — ADD
427,864 shares ($1.3M)
SBC Medical Group announced a consulting partnership with BLEZ ASIA to open a new aesthetic dermatology section in…
Impact 2/10
SBC Medical Group Holdings Incorporated announced it will report its Q1 2026 results on May 14, 2026.
PRESS-RELEASE — Impact 1/10
Apr 28, 2026 Insider
Aikawa Yoshiyuki sold 465,000 shares
Chairman and CEO @ $3.02 ($1.4M)
Apr 21, 2026 Insider
Aikawa Yoshiyuki sold 3,100,000 shares
Chairman and CEO @ $3.02 ($9.4M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Recent
Sep 25, 2026
Press release
SBC Medical to Participate in Several Upcoming Investor Conferences in October 2026
SBC Medical announces its participation in 3 upcoming investor conferences in Oct 2026, featuring presentations and 1on1 meetings with investors.
Aug 13, 2026
Earnings date
SBC Q2 2026 Earnings Scheduled — 2026-08-13
Jul 17, 2026
Listing
Listing Status: SBC — Deficient (was Normal)
SBC Medical Group Holdings Incorporated - Common Stock | Nasdaq Financial Status Indicator N → D
May 26, 2026
Press release
SBC Medical will participate in several upcoming investor conferences in May and June 2026
SBC will participate in several upcoming investor conferences in May and June 2026.
May 22, 2026
Contract
SBC Medical and BLEZ ASIA Celebrate Opening of New Aesthetic Dermatology Section at BLEZ CLINIC in Bangkok
Japanese-Quality Pico Laser Treatment to Serve the Growing Thai Aesthetic Healthcare Market, with Service Launch Scheduled for June 2026…
SecBot reports
2 filings · 1 press release · 0 bullish · 1 bearish · 1 neutral- BEARISH 8-KJul 14, 2026
SBC Medical Group Holdings disclosed it is non-compliant with Nasdaq's independent director and…
Monitor SBC's progress in appointing a fifth independent director. Failure to regain Nasdaq compliance by the cure deadline could lead to delisting, severely impacting liquidity. The governance…
- NEUTRAL PRESS RELEASEMay 22, 2026
SBC Medical Group announced a consulting partnership with BLEZ ASIA to open a new aesthetic…
This is a routine business development announcement with no material financial impact. Traders should await upcoming quarterly results for any revenue contribution from this partnership. Monitor for…
- NEUTRAL PRESS-RELEASEMay 1, 2026
SBC Medical Group Holdings Incorporated announced it will report its Q1 2026 results on May 14…
All SBC filing & press-release reports (3)
- 8-K reportJul 14, 2026
- PRESS-RELEASE reportMay 22, 2026
- PRESS-RELEASE reportMay 1, 2026